Primaltherapies
1 known investors
Primal Therapies develops microbial biotechnology, including patented small molecule drugs and functional ingredients for biofilm management, infection control, and microbiome modulation. Its SMMRT platform targets metabolic receptors and enzymes in bacteria, viruses, and fungi to address antimicrobial resistance, disinfection, and chronic disease across healthcare and other industries.
Investors · 1
Frequently asked questions
- What does Primaltherapies do?
- Primal Therapies develops microbial biotechnology, including patented small molecule drugs and functional ingredients for biofilm management, infection control, and microbiome modulation. Its SMMRT platform targets metabolic receptors and enzymes in bacteria, viruses, and fungi to address antimicrobial resistance, disinfection, and chronic disease across healthcare and other industries.
- Who are Primaltherapies's investors?
- Primaltherapies's investors include P5 Health Ventures.